
Latest Science News
Cambridge Scientists Develop Light-Based Drug Modification Technique
University of Cambridge researchers created an 'anti-FriedelâCrafts' reaction using LED light to alter complex drug molecules at late production stages, avoiding toxic chemicals and harsh conditions. This selective method forms carbon-carbon bonds under mild conditions, accelerating drug design and reducing waste. AI models predict reaction sites, enhancing efficiency.
ATTD 2026 Unveils Advances in Type 1 Diabetes Treatments
At the ATTD 2026 conference in Barcelona, researchers highlighted AI-driven closed-loop insulin systems like AIDANET using Dexcom G6 and Tandem pumps for automated delivery. Gene therapy trials in large animals normalized blood glucose for years, with human Phase 1 trials starting this year.
Breakthrough T1D supports disease-modifying therapies like Tzield.
MDA Conference Showcases Neuromuscular Disease Breakthroughs
The 2026 MDA Clinical & Scientific Conference featured advances in gene editing, RNA therapies, and biomarkers for neuromuscular disorders. Over 2,400 attendees discussed muscle regeneration and clinical trial optimization.
Ćukasz Sznajder received the inaugural Research Momentum Award for work on myotonic dystrophy and ALS.
NASA's Artemis Program Ushers in Lunar Science Era
NASA's Artemis aims for sustained Moon presence, enabling heavier payloads via Space Launch System for missions and telescopes like Habitable Worlds Observatory. Lunar samples will reveal early solar system history and aid life detection on Mars.
The program serves as a deep space research launchpad despite delays.
OPCW Report on AI's Impact on Chemical Weapons Convention
The OPCW's Scientific Advisory Board released a report on AI transforming chemical research, synthesis planning, and threat detection. AI aids in analyzing satellite data and spectral datasets for inspections and security.
It highlights shifts in automated labs, urging updates to chemical activity indicators.
Oxford-Harrington Turns Rare Disease Science into Medicines
Oxford-Harrington initiative advances breakthrough science into life-changing medicines for rare diseases, highlighted March 12, 2026. Focuses on patient stories and therapeutic development.
Emphasizes translating research to clinical impact.